ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.48
0.00%
US Tech 100
18,200.00
0.30%
S&P 500
5,267.84
-0.74%
US Dollar vs CAD
1.37178
-0.11%
Bitcoin
67,401.33
-0.77%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
05/24/20246:15AMPR Newswire (Canada)ARTIS REAL ESTATE INVESTMENT TRUST ANNOUNCES VOTING RESULTS FROM THE 2024 ANNUAL MEETING OF UNITHOLDERSTSX:AX.UNArtis Real Estate Investment Trust
05/24/20246:14AMPR Newswire (US)Rokid AR Lite: The first AR glasses powered by Snapdragon® 6 Gen 1 mobile platform
05/24/20246:14AMPR Newswire (US)Titans of Tech: GP Bullhound releases its annual report on the European tech ecosystem
05/24/20246:13AMPR Newswire (US)Hailup Influencers Mobile App: Revolutionizing Global Connection for Caribbean Influencers and Celebrities
05/24/20246:13AMPR Newswire (US)Unlocking the Next Level: Esteemed fashion leaders assemble in Copenhagen to catalyse and accelerate sustainability progress
05/24/20246:09AMPR Newswire (US)Titans of Tech: GP Bullhound releases its annual report on the European tech ecosystem
05/24/20246:02AMPR Newswire (US)HI-Bio Presents Positive Interim Results from Phase 2 IGNAZ Study of Felzartamab in IgA Nephropathy at 61st European Renal Association (ERA) Congress
05/24/20246:01AMPR Newswire (US)Matt Epstein Joins Travelzoo's Global Executive TeamNASDAQ:TZOOTravelzoo
05/24/20246:00AMPR Newswire (Canada)Canadian retailers enhancing customer experience through generative AI, finds KPMG in Canada survey
05/24/20246:00AMPR Newswire (Canada)/R E P R I S E -- AVIS AUX MÉDIAS - Les ministres Holland et Khera présenteront les investissements du Budget de 2024 à Scarborough/
05/24/20246:00AMPR Newswire (Canada)/R A P P E L -- Avis aux médias - Itinéraire du premier ministre pour le vendredi 24 mai 2024/
05/24/20246:00AMPR Newswire (Canada)/R E P R I S E -- INVITATION AUX MÉDIAS : PROJET D'HABITATION ABORDABLE À SAINTE-GENEVIÈVE-DE-BATISCAN/
05/24/20246:00AMPR Newswire (Canada)/R E P R I S E --INVITATION AUX MÉDIAS : NOUVEAU PROJET D'HABITATION ABORDABLE À SAINT-CALIXTE/
05/24/20246:00AMPR Newswire (Canada)/R E P E A T -- MEDIA ADVISORY - GOVERNMENTS OF CANADA, QUEBEC, AND THE CITY OF TROIS-RIVIÈRES TO MAKE A HOUSING-RELATED ANNOUNCEMENT IN TROIS-RIVIÈRES/
05/24/20246:00AMPR Newswire (Canada)/R E P R I S E -- AVIS AUX MÉDIAS - LES GOUVERNEMENTS DU CANADA, DU QUÉBEC, ET LA VILLE DE TROIS-RIVIÈRES FERONT UNE ANNONCE SUR LE LOGEMENT À TROIS-RIVIÈRES/
05/24/20246:00AMPR Newswire (Canada)Un sondage de KPMG au Canada révèle que les détaillants canadiens améliorent l'expérience client grâce à l'IA générative
05/24/20246:00AMPR Newswire (Canada)Pour le patient - Un agent de prévention des complications du virus respiratoire syncytial chez les bébés disponible dès l'automne prochain
05/24/20246:00AMPR Newswire (Canada)/R E P R I S E -- INVITATION AUX MÉDIAS - Conférence de presse concernant Cintech agroalimentaire, le centre d'innovation et de recherche appliquée affilié au Cégep de Saint-Hyacinthe/
05/24/20246:00AMPR Newswire (Canada)/R E P R I S E -- AVIS AUX MÉDIAS - ANNONCE CONCERNANT LE LOGEMENT À SAINTE-GENEVIÈVE-DE-BATISCAN/
05/24/20246:00AMPR Newswire (Canada)/R E P R I S E --AVIS AUX MÉDIAS - LES GOUVERNEMENTS DU CANADA, DU QUÉBEC, ET DE LA MUNICIPALITÉ DE SAINT-CALIXTE FERONT UNE ANNONCE SUR LE LOGEMENT À SAINT-CALIXTE/
05/24/20246:00AMPR Newswire (Canada)/R E P E A T -- MEDIA ADVISORY - FEDERAL GOVERNMENT TO MAKE HOUSING ANNOUNCEMENT IN SAULT STE. MARIE/
05/24/20246:00AMPR Newswire (Canada)/R E M I N D E R -- Media Advisory - Prime Minister's itinerary for Friday, May 24, 2024/
05/24/20246:00AMPR Newswire (Canada)/R E P R I S E -- AVIS AUX MÉDIAS - Mêlée de presse du chef de l'opposition officielle/
05/24/20246:00AMPR Newswire (Canada)LA CHIMISTE CHRISTIANE AYOTTE REÇOIT LE PRIX RENÉ DUSSAULT 2024
05/24/20246:00AMPR Newswire (Canada)61st ERA Congress: Semaglutide significantly reduces risk of major kidney disease events, cardiovascular outcomes and mortality in patients with type 2 diabetes and chronic kidney disease, groundbreaking study reveals
05/24/20246:00AMPR Newswire (Canada)/R E P E A T -- MEDIA ADVISORY - HOUSING ANNOUNCEMENT IN SAINTE-GENEVIÈVE-DE-BATISCAN/
05/24/20246:00AMPR Newswire (Canada)/R E P E A T -- NOTICE TO THE MEDIA - Ministers Holland and Khera to highlight Budget 2024 investments in Scarborough/
05/24/20246:00AMPR Newswire (Canada)/R E P R I S E -- AVIS AUX MÉDIAS - LE GOUVERNEMENT FÉDÉRAL FERA UNE ANNONCE SUR LE LOGEMENT À SAULT STE. MARIE/
05/24/20246:00AMPR Newswire (Canada)/R E P E A T -- MEDIA ADVISORY - GOVERNMENTS OF CANADA, QUEBEC, AND THE TOWN OF SAINT-CALIXTE TO MAKE A HOUSING-RELATED ANNOUNCEMENT IN SAINT-CALIXTE/
05/24/20246:00AMPR Newswire (Canada)MEDIA ADVISORY - 99-Year-Old Raises $250,000 Over 10 Years Walking for the Alzheimer Society

Your Recent History

USOTC
TDRK
TideRock Companies (PK)
USOTC
AHRO
Authentic (CE)
USOTC
SHMP
NaturalShrimp (QB)
USOTC
AABB
Asia Broadband (PK)
NASDAQ
RVNC
Revance Therapeutics
USOTC
DPLS
DarkPulse (PK)
USOTC
AFFU
Affluence (PK)
USOTC
VXIT
Virexit Technologies (PK)
NASDAQ
NVDA
NVIDIA
USOTC
MVNT
Movement Industries (PK)
NASDAQ
NB
NioCorp Developments
NASDAQ
SINT
SiNtx Technologies
USOTC
QEDN
QED Connect (PK)
USOTC
PSRU
Valiant Eagle (PK)
USOTC
CATV
4Cable TV (PK)
AMEX
SPY
SPDR S&P 500
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved